Literature DB >> 8434395

Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys.

D A Corral1, F S Darras, C W Jensen, T R Hakala, S J Naides, J R Krause, T E Starzl, M L Jordan.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8434395      PMCID： PMC3154770          DOI： 10.1097/00007890-199302000-00035

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  9 in total

1.  Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

Authors:  G J Kurtzman; B Cohen; P Meyers; A Amunullah; N S Young
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

2.  Myocarditis caused by parvovirus.

Authors:  J Saint-Martin; J J Choulot; E Bonnaud; F Morinet
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

3.  Parvovirus infection after renal transplant.

Authors:  G Neild; M Anderson; S Hawes; B T Colvin
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

4.  Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia.

Authors:  D K Van Horn; P P Mortimer; N Young; G R Hanson
Journal:  Am J Pediatr Hematol Oncol       Date:  1986

5.  Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

Authors:  N Frickhofen; J L Abkowitz; M Safford; J M Berry; J Antunez-de-Mayolo; A Astrow; R Cohen; I Halperin; L King; D Mintzer
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

6.  [Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation].

Authors:  H Niitsu; H Takatsu; I Miura; A Chubachi; T Ito; M Hirokawa; Y Endo; A Miura; M Fukuda; T Sasaki
Journal:  Rinsho Ketsueki       Date:  1990-09

7.  Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience.

Authors:  S J Naides; L L Scharosch; F Foto; E J Howard
Journal:  Arthritis Rheum       Date:  1990-09

8.  Human parvovirus arthropathy.

Authors:  D G White; A D Woolf; P P Mortimer; B J Cohen; D R Blake; P A Bacon
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

9.  Aplastic crisis in sickle cell disorders: bone marrow necrosis and human parvovirus infection.

Authors:  M E Conrad; H Studdard; L J Anderson
Journal:  Am J Med Sci       Date:  1988-03       Impact factor: 2.378
  9 in total
  3 in total

Review 1.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

2.  Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia.

Authors:  Shigeki Ito; Tatsuo Oyake; Toshiyuki Uchiyama; Takeshi Sugawara; Kazunori Murai; Yoji Ishida
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

Review 3.  Donor infection: an opinion on lung donor utilization.

Authors:  Edward R Garrity; Heidi Boettcher; Eli Gabbay
Journal:  J Heart Lung Transplant       Date:  2005-07       Impact factor: 10.247
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.